L
LAVENDER
Botanical Names: | Lavandula officinalis, Lavandula angustifolia,#∧Lavandula angustifolia subsp. angustifolia,#Lavandula vera# |
Family: | Labiatae |
Plant Part Used: | Flower |
∧ Adopted by the American Herbal Products Association as the new botanical name.1
PRESCRIBING INFORMATION
Actions | Carminative, spasmolytic, antidepressant, anxiolytic | |
Potential Indications | Based on appropriate evaluation of the patient, practitioners should consider prescribing lavender in formulations in the context of: • Functional abdominal complaints, such as nervous stomach irritations and meteorism (i.e., gaseous distension of the abdomen or intestine) (4) | |
Contraindications | None known. | |
Warnings and Precautions | None required. | |
Interactions | None known. | |
Use in Pregnancy and Lactation | No adverse effects expected. | |
Side Effects | None expected if taken within the recommended dose range. High (undefined) doses are said to cause abdominal pain and colic.2,3 | |
Dosage | Dose per day** | Dose per week** |
2.0-4.5 ml of 1:2 liquid extract | 15-30 ml of 1:2 liquid extract |
* Based on the assumption that oral dosage of lavender infusion or liquid extract would deliver a similar concentration of active constituents to the bloodstream as would topical use (or inhalation) of lavender essential oil.
** This dose range is extrapolated from the British Herbal Pharmacopoeia 1983 and the author’s education and experience.
SUPPORTING INFORMATION
1 McGuffin M, editor. Herbs of commerce, ed 2, Bethesda, Md: American Herbal Products Association, 1998. [draft 3.3]
2 Felter HW, Lloyd JU. King’s American dispensatory, ed 18. Portland: Eclectic Medical Publications, 1905. rev 3, reprinted 1983
3 Grieve M. A modern herbal. New York: Dover Publications, 1971.
4 British Herbal Medicine Association’s Scientific Committee. British herbal pharmacopoeia. Bournemouth: BHMA, 1983.
5 Weiss RF. Herbal medicine, English ed. Beaconsfield, UK: Beaconsfield Publishers, 1988.
6 Wagner H, Bladt S. Plant drug analysis: a thin layer chromatography atlas, ed 2. Berlin: Springer-Verlag, 1996.
7 Bisset NG, editor. Herbal drugs and phytopharmaceuticals. Stuttgart: Medpharm Scientific Publishers, 1994.
8 Bradshaw RH, et al. J Altern Complement Med. 1998;4(3):271-275.
9 Hohmann J, et al. Planta Med. 1999;65(6):576-578.
10 Izzo AA, et al. Phytother Res. 1996;10(suppl 1):S107-S108.
11 Lis-Balchin M, Hart S. J Ethnopharmacol. 1997;58(3):183-187.
12 Lis-Balchin M, Hart S. Phytother Res. 1999;13(6):540-542.
13 Buchbauer G, et al. Z Naturforsch [C]. 1991;46(11-12):1067-1072.
14 Guillemain J, Rousseau A, Delaveau P. Ann Pharm Fr. 1989;47(6):337-343.
15 Delaveau P, et al. C R Seances Soc Biol Fil. 1989;183(4):342-348.
16 Nikolaevskii VV, et al. Patol Fiziol Eksp Ter. 1990;(5):52-53.
17 Yamada K, Mimaki Y, Sashida Y. Biol Pharm Bull. 1994;17(2):359-360.
18 Larrondo JV, Agut M, Calvo-Torras MA. Microbios. 1995;82(332):171-172.
19 Inouye S, et al. Mycoses. 1998;41(9-10):403-410.
20 Adam K, et al. J Agri Food Chem. 1998;46(5):1739-1745.
21 Kim HM, Cho SH. J Pharm Pharmacol. 1999;51(2):221-226.
22 Kedzia B, et al. Herba Polon. 1998;44(2):126-135.
23 Jager W, et al. J Soc Cosm Chem. 1992;43:49-54.
24 Buchbauer B, et al. Teranishi R, Buttery RG, Sugisawa H, editors. Bioactive volatile compounds from plants. ACS Symposium series. Washington, DC: American Chemical Society, 1993. Cited in
25 Itai T, et al. Psychiatry Clin Neurosci. 2000;54(4):393-397.
26 Vernet-Maury E, et al. J Auton Nerv Syst. 1999;75(2-3):176-183.
27 Diego MA, et al. Int J Neurosci. 1998;96(3-4):217-224.
28 Dunn C, Sleep J, Collett D. J Adv Nurs. 1995;21(1):34-40.
29 Romine IJ, Bush AM, Geist CR. Percept Mot Skills. 1999;88(3, pt 1):756-758.
30 Motomura N, Sakurai A, Yotsuya Y. Memoir Osaka Kyoiku Univ III Nat Sci Appl Sci. 1999;47(2):281-287.
31 Dale A, Cornwell S. J Adv Nurs. 1994;19(1):89-96.
32 Cornwell S, Dale A. Mod Midwife. 1995;5(3):31-33.
33 Tysoe P. Int J Nurs Pract. 2000;6(2):110-112.
34 Hardy M, Kirk-Smith MD, Stretch DD. Lancet. 1995;346(8976):701.
35 Emmerling M, et al. Z Phytother Abstractband. 1995:25.
36 Saeki Y. Complement Ther Med. 2000;8(1):2-7.
37 Blumenthal M, et al, editors. The complete German Commission E monographs: therapeutic guide to herbal medicines. Austin: American Botanical Council, 1998.
LEMON BALM
Other Common Name: | Melissa |
Botanical Name: | Melissa officinalis |
Family: | Labiatae |
Plant Part Used: | Aerial parts |
PRESCRIBING INFORMATION
Actions | Carminative, spasmolytic, mild sedative, diaphoretic, TSH antagonist, antiviral (topically) | |
Potential Indications | Based on appropriate evaluation of the patient, practitioners should consider prescribing lemon balm in formulations in the context of: | |
Contraindications | None known. | |
Warnings and Precautions | None required. | |
Interactions | None known. | |
Use in Pregnancy and Lactation | No adverse effects expected. | |
Side Effects | None expected if taken within the recommended dose range. | |
Dosage | Dose per day* | Dose per week* |
3-6 ml of 1:2 liquid extract | 20-40 ml of 1:2 liquid extract |
* This dose range is extrapolated from the British Herbal Pharmacopoeia 1983 and the author’s education and experience.